Cargando…
Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women
BACKGROUND: The combination of genistein 27 mg, cholecalciferol 200 IU, citrated zinc bisglycinate (4 mg elemental zinc) 20 mg per capsule in Fosteum(®), a prescription medical food regulated by the FDA and indicated for the dietary management of osteopenia and osteoporosis, was tested for drug inte...
Autores principales: | Burnett, Bruce P, Pillai, Lakshmi, Bitto, Alessandra, Squadrito, Francesco, Levy, Robert M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140810/ https://www.ncbi.nlm.nih.gov/pubmed/21792336 http://dx.doi.org/10.2147/IJWH.S19309 |
Ejemplares similares
-
The Steady-State Serum Concentration of Genistein Aglycone Is Affected by Formulation: A Bioequivalence Study of Bone Products
por: Bitto, Alessandra, et al.
Publicado: (2013) -
Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
por: Burnett, Bruce P., et al.
Publicado: (2011) -
Zein Beta-Cyclodextrin Micropowders for Iron Bisglycinate Delivery
por: Esposito, Diletta, et al.
Publicado: (2020) -
Update on genistein and thyroid: an overall message of safety
por: Marini, Herbert, et al.
Publicado: (2012) -
Corrigendum: Update on genistein and thyroid: an overall message of safety
por: Marini, Herbert, et al.
Publicado: (2022)